mda-mb-468 glutathione content Frontiers Small Peptide Ligands for Targeting
Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells Scientific Reports a) Timeline for the creation of the orthotopic MDA MB 468 breast Download Scientific Diagram Evaluation of MDA MB 468 Cell Culture Media Analysis in Predicting Triple Negative Breast Cancer Patient Sera Metabolic Profiles PMC Disclosing a metabolic signature of cisplatin resistance in MDA MB 231 triple negative breast cancer cells by NMR metabolomics Cancer Cell International Springer Nature Link MDA MB 468 an overview ScienceDirect Topics
Pay in 4 interest-free payments of $5.90 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




